Cricket Protein Bioavailability in Younger, Middle-Aged and Older Adults (CriProB)

March 25, 2025 updated by: University of Surrey

Cricket Protein Bioavailability in Younger, Middle-Aged and Alder Adults

A global shift towards sustainable food sources is now emerging, largely due to the immense environmental pressure that comes from producing animal foods, particularly beef. Insects present a novel source of sustainable dietary protein due to their high protein content. This is particularly relevant for older adults, as protein becomes increasingly more important in later life. It helps to maintain muscle as we age, which is crucial for reducing frailty, falls and early mortality. We want to find out more about the digestion and absorption of insect protein in older people to see if it could be a beneficial source of protein to help maintain muscle. We are interested in the use of insect-based solid foods, especially the use of flour made from grounded whole crickets. We want to explore the digestibility of cricket protein compared to a commonly used animal alternative (whey protein) to find out if it can be efficiently absorbed and utilised within humans.

Study Overview

Detailed Description

Participants are asked to fast overnight and come in the following day for one of two visits where they are given a standardised breakfast muffin containing either cricket protein or whey protein (250-300 kcal; approx. 12% fat, 45% carbohydrates including 10% sugars, 35% protein, 0.4% salt and 6% fibre) after which they breathe into a test tube in 15-30 minute intervals for 4 hours. In addition to this, we collect a blood sample (10ml) every 15 minutes for the first hour and then every 30 minutes for the next 3 hours (110ml of blood in total per visit) so we can determine changes in blood amino acids, glucose and fat concentrations after eating the muffin. In total we only collect a small amount of blood. This method of blood collection is the same method used for a traditional blood test but to avoid repeated needle insertions we use a cannula which remains in the participant's arm for the duration of the visit so that only a single needle insertion is necessary.

The muffin contains a small amount of a natural fat called octanoic acid. The octanoic acid is enriched with carbon-13. This is a natural variant of carbon and is safe to use, even in babies and pregnant women. At the end of each test visit we ask participants to fill out a short questionnaire to ask about the taste of the muffins. Participants are required to repeat this whole process for a second visit in which they consume the other muffin.

The muffins are identical between the two test visits with the exception that one muffin is made with a milk-based protein (whey) whereas the other test muffin is made with an insect protein (cricket). The test muffins are similar in size, shape, and taste. Participants are randomised to a muffin condition in a crossover design. Participants are blinded to the muffin condition and only one member of the research team knows which muffin participants receive on which test visit but they are not present during the test visits. The researchers conducting the test visits do not know which muffin is being consumed by participants.

Participants are required to attend for 2 test visits each lasting approximately 5 hours. This takes place in the Clinical Investigation Unit (CIU) at the University of Surrey. On the day before each of the test visits participants are asked to arrive fasted for 12 hours overnight, refrain from strenuous exercise, alcohol, caffeine and food containing corn, broccoli, sugarcane, and tropical fruits (because of the type of natural carbon-13 they contain) the day before their visits.

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Surrey
      • Guildford, Surrey, United Kingdom, GU2 7XH
        • University of Surrey

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy adult males and females in general good health, aged between 18 - 35 years, 40 - 55 years or over 65 years
  • BMI between 18.5 and 35 kg/m2
  • Stable weight for at least 3 months
  • Volunteers must be able and willing to give informed written consent
  • Volunteers must be able to eat egg
  • Volunteers must be willing to provide blood samples

Exclusion Criteria:

  • Current or previous gastrointestinal conditions (e.g. Crohn's disease, Coeliac disease, Irritable Bowel Syndrome) - assessed via a health questionnaire
  • Those with diabetes or other metabolic conditions - assessed via a health questionnaire
  • Those taking food supplements which may impact digestion (e.g., digestive enzymes, probiotics, fibre supplements)
  • Those smoking, using nicotine products (e.g., e-cigarettes, patches) or not abstained from these activities for more than 6 months - assessed via a health questionnaire
  • Pregnant or lactating
  • Volunteers with a high daily caffeine intake > 300 mg/day (more than 5 cups of standard coffee per day)
  • Drug or alcohol abuse in the last 2 years
  • Those who are currently taking part in a clinical trial or another research study or have taken part within the last 3 months
  • Those with food allergies, dietary intolerance or Coeliac disease - assessed via a health questionnaire
  • Those following weight loss diets

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cricket muffin
Muffin made with cricket-derived protein powder
Muffins made with cricket-derived protein from house crickets (Acheta domesticus )
Active Comparator: Whey muffin
Muffin made with whey protein powder
Muffins made with whey protein

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastric emptying
Time Frame: 4 hour post-prandial period
Exhaled breath is used to assess the rate of gastric emptying of the protein muffins
4 hour post-prandial period
Plasma amino acids
Time Frame: 4 hour post-prandial period
Blood samples are used to assess the plasma amino acid response to consuming the protein muffins
4 hour post-prandial period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Metabolic markers
Time Frame: 4 hour post-prandial period
Blood samples are also used to assess post-prandial glucose, triglycerides and cholesterol
4 hour post-prandial period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

HOP

Investigators

  • Study Director: James Rutherford, MSc, University of Surrey

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 11, 2024

Primary Completion (Actual)

March 10, 2025

Study Completion (Actual)

March 10, 2025

Study Registration Dates

First Submitted

January 8, 2025

First Submitted That Met QC Criteria

March 25, 2025

First Posted (Actual)

April 2, 2025

Study Record Updates

Last Update Posted (Actual)

April 2, 2025

Last Update Submitted That Met QC Criteria

March 25, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CriProB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Whey Protein

Clinical Trials on Cricket protein

Subscribe